Yusheng Shu

582 citations
27 papers · 395 indexed · h-index 13
Topics
Gastric Cancer Management and Outcomes (3 papers)Cancer, Hypoxia, and Metabolism (3 papers)Epigenetics and DNA Methylation (3 papers)
Partner nations
ChinaNetherlands

In The Last Decade

Yusheng Shu

24 papers receiving 391 citations

Peers

Yusheng Shu
Comparison fields: 5 of 79
  • Molecular Biology 165
  • Pulmonary and Respiratory Medicine 77
  • Cancer Research 69
  • Surgery 63
  • Oncology 56
Replace Igor Shmarakov with:
Igor Shmarakov Ukraine
Minggang Wei China
Fuda Xie China
Po-Lin Liao Taiwan
Aihua Bao China
Shuaijun Lu China
Ok Kim South Korea
Xinjia He China
Rachid Seqqat Ecuador
Jiuxin Zhu China
Yusheng Shu relative to Igor Shmarakov Ukraine Igor Shmarakov's profile →
Citations per field
00.5×3.0×
Igor Shmarakov · 1×
Citations per year

Countries citing papers authored by Yusheng Shu

Since Specialization
Citations

This map shows the geographic impact of Yusheng Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusheng Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusheng Shu more than expected).

Fields of papers citing papers by Yusheng Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusheng Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusheng Shu. The network helps show where Yusheng Shu may publish in the future.

Co-authorship network of co-authors of Yusheng Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Yusheng Shu. A scholar is included among the top collaborators of Yusheng Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusheng Shu. Yusheng Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 2
4 0
5 4
6 2
7 20
8 10
9 19
10 14
11 38
12 2
13 43
14 25
15 7
16 11
17 33
18 1
19
Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
12
20 46

About Yusheng Shu

Yusheng Shu is a scholar working on Cancer Research, Biochemistry and Biomaterials, having authored 27 papers that have together received 395 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Biochemistry (39 citations), Cancer Research (69 citations) and Pharmacology (33 citations). Yusheng Shu has collaborated with scholars based in China and Netherlands. Frequent co-authors include Wei Tao, Hongcan Shi, Weiping Shi, Yabing Zhu, Shichun Lu, Shichun Lu, Xiaolong Yuan, Qianqian Cao, Wenhui Li and Kang Wang. Their work appears in journals such as Frontiers in Immunology, Cancer Letters and Medical Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026